Determination of vincristine in infant plasma by liquid chromatography-atmospheric pressure chemical ionization-mass spectroscopy

Mark S. Schmidt, Rong Huang, Robert J. Classon, Daryl J Murry

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

An LC-MS method using APCI has been developed and validated for the determination of the anticancer drug vincristine in human plasma, using vinblastine as internal standard. Following solid-phase extraction (SPE) of the sample, the lower limit of quantitation (LLOQ) was 0.18 ng/ml, the lower limit of detection was 0.09 ng/ml, and the linear calibration range was 0.18-180 ng/ml. This method has been used to measure plasma concentrations of vincristine from 0.08 to 24 h post bolus in 29 infants as part of a pharmacokinetic study. Concentrations of vincristine at 24 h were 0.2-1.36 ng/ml.

Original languageEnglish (US)
Pages (from-to)540-543
Number of pages4
JournalJournal of Pharmaceutical and Biomedical Analysis
Volume41
Issue number2
DOIs
StatePublished - May 3 2006

Fingerprint

Atmospheric Pressure
Liquid chromatography
Vincristine
Liquid Chromatography
Atmospheric pressure
Ionization
Mass Spectrometry
Spectroscopy
Plasmas
Plasma (human)
Pharmacokinetics
Vinblastine
Solid Phase Extraction
Calibration
Limit of Detection
Pharmaceutical Preparations

Keywords

  • APCI
  • Analysis
  • Infant
  • LC-MS
  • Pediatric
  • Plasma
  • Vinblastine
  • Vincristine
  • Vinorelbine

ASJC Scopus subject areas

  • Analytical Chemistry
  • Pharmaceutical Science

Cite this

Determination of vincristine in infant plasma by liquid chromatography-atmospheric pressure chemical ionization-mass spectroscopy. / Schmidt, Mark S.; Huang, Rong; Classon, Robert J.; Murry, Daryl J.

In: Journal of Pharmaceutical and Biomedical Analysis, Vol. 41, No. 2, 03.05.2006, p. 540-543.

Research output: Contribution to journalArticle

@article{ecf5df22e37c46999d59a69bca1269bb,
title = "Determination of vincristine in infant plasma by liquid chromatography-atmospheric pressure chemical ionization-mass spectroscopy",
abstract = "An LC-MS method using APCI has been developed and validated for the determination of the anticancer drug vincristine in human plasma, using vinblastine as internal standard. Following solid-phase extraction (SPE) of the sample, the lower limit of quantitation (LLOQ) was 0.18 ng/ml, the lower limit of detection was 0.09 ng/ml, and the linear calibration range was 0.18-180 ng/ml. This method has been used to measure plasma concentrations of vincristine from 0.08 to 24 h post bolus in 29 infants as part of a pharmacokinetic study. Concentrations of vincristine at 24 h were 0.2-1.36 ng/ml.",
keywords = "APCI, Analysis, Infant, LC-MS, Pediatric, Plasma, Vinblastine, Vincristine, Vinorelbine",
author = "Schmidt, {Mark S.} and Rong Huang and Classon, {Robert J.} and Murry, {Daryl J}",
year = "2006",
month = "5",
day = "3",
doi = "10.1016/j.jpba.2005.11.039",
language = "English (US)",
volume = "41",
pages = "540--543",
journal = "Journal of Pharmaceutical and Biomedical Analysis",
issn = "0731-7085",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Determination of vincristine in infant plasma by liquid chromatography-atmospheric pressure chemical ionization-mass spectroscopy

AU - Schmidt, Mark S.

AU - Huang, Rong

AU - Classon, Robert J.

AU - Murry, Daryl J

PY - 2006/5/3

Y1 - 2006/5/3

N2 - An LC-MS method using APCI has been developed and validated for the determination of the anticancer drug vincristine in human plasma, using vinblastine as internal standard. Following solid-phase extraction (SPE) of the sample, the lower limit of quantitation (LLOQ) was 0.18 ng/ml, the lower limit of detection was 0.09 ng/ml, and the linear calibration range was 0.18-180 ng/ml. This method has been used to measure plasma concentrations of vincristine from 0.08 to 24 h post bolus in 29 infants as part of a pharmacokinetic study. Concentrations of vincristine at 24 h were 0.2-1.36 ng/ml.

AB - An LC-MS method using APCI has been developed and validated for the determination of the anticancer drug vincristine in human plasma, using vinblastine as internal standard. Following solid-phase extraction (SPE) of the sample, the lower limit of quantitation (LLOQ) was 0.18 ng/ml, the lower limit of detection was 0.09 ng/ml, and the linear calibration range was 0.18-180 ng/ml. This method has been used to measure plasma concentrations of vincristine from 0.08 to 24 h post bolus in 29 infants as part of a pharmacokinetic study. Concentrations of vincristine at 24 h were 0.2-1.36 ng/ml.

KW - APCI

KW - Analysis

KW - Infant

KW - LC-MS

KW - Pediatric

KW - Plasma

KW - Vinblastine

KW - Vincristine

KW - Vinorelbine

UR - http://www.scopus.com/inward/record.url?scp=33645959550&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645959550&partnerID=8YFLogxK

U2 - 10.1016/j.jpba.2005.11.039

DO - 10.1016/j.jpba.2005.11.039

M3 - Article

VL - 41

SP - 540

EP - 543

JO - Journal of Pharmaceutical and Biomedical Analysis

JF - Journal of Pharmaceutical and Biomedical Analysis

SN - 0731-7085

IS - 2

ER -